Intravenous IRON supplementation in Heart Failure with Preserved Ejection Fraction and iron deficiency (IRON-HFpEF): a comprehensive phase II multicentre placebo-controlled randomized clinical trial
Open Access
- 18 May 2026
- journal article
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
Abstract
Aims: Iron deficiency (ID) is common in patients with heart failure with preserved ejection fraction (HFpEF). The IRON-HFpEF trial aimed to evaluate the mechanistic effects of intravenous iron supplementation on cardiovascular function and exercise tolerance in HFpEF. Methods: 45 patients with HFpEF (LV ejection fraction ≥50%) and ID were recruited from Amsterdam UMC and Maastricht UMC+. Patients with ID-anaemia were excluded. Patients were randomized to receive either ferric carboxymaltose (FCM) or placebo. At baseline and 4 months, assessments included exercise right heart catheterization, 6-minute walking distance (6MWD), cardiac MRI, exercise calf muscle 31P-magnetic resonance spectroscopy, and laser speckle contrast analysis. There was also an open-label extension. Results: Patients were in functional class II-III. FCM had no effect on pulmonary capillary wedge pressure during multiple levels of exercise (mean change −1.0 mmHg, 95% CI [−4, 2]; P = .52). FCM did not change myocardial PCr/ATP ratio (P = .18), calf muscle PCr recovery time (P = .11), NT-proBNP (P = .78), or Kansas City Cardiomyopathy Questionnaires (P = .67). However, FCM led to an improvement in right ventricular ejection fraction (FCM: +4 ± 5% vs placebo: −3 ± 6%; P = .002) and acetylcholine-mediated microvascular perfusion (FCM: +5 ± 24 vs placebo: −16 ± 25 a.u.; P = .04), and seemed to marginally improve 6MWD (+6 ± 31 m vs −13 ± 31 m; P = .06). After correction for baseline differences, FCM improved 6MWD (+28 m; P = .01). Conclusion: In patients with HFpEF and ID without ID-anaemia, FCM did not improve exercise hemodynamics, LV diastolic function, myocardial or skeletal energy homeostasis. Exploratory analyses suggest that FCM does improve exercise tolerance (6MWD), potentially through improvement of microvascular endothelial function and RV function.Keywords
Funding Information
- Vifor
- Netherlands CardioVascular Research Initiative Consortium (CVON, 2018-29: PHAEDRA-IMPACT, 2017-10)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO-VIDI: 917.18.338)
- Hartstichting (2018T059)
- Hartstichting (2020T058)
- Hartstichting (2020B008: RECONNEXT)
- National Institutes of Health (R01 HL173346)
This publication has 30 references indexed in Scilit:
- Ferric carboxymaltose and exercise capacity in heart failure with preserved ejection fraction and iron deficiency: the FAIR-HFpEF trialEuropean Heart Journal, 2024
- Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemiaHemaSphere, 2024
- Systematic Review and Meta-Analysis of Intravenous Iron-Carbohydrate Complexes in HFrEF Patients with Iron DeficiencyESC Heart Failure, 2022
- Ferric carboxymaltose in patients with pulmonary arterial hypertension and iron deficiency: a long‐term studyJournal of Cachexia, Sarcopenia and Muscle, 2021
- Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trialThe Lancet, 2020
- Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fractionActa Cardiologica, 2017
- Mitochondria and Iron: current questionsExpert Review of Hematology, 2016
- Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiencyEuropean Heart Journal, 2014
- Ferric carboxymaltose improves exercise capacity and quality of life in patients with pulmonary arterial hypertension and iron deficiency: A pilot studyInternational Journal of Cardiology, 2014
- Heart Failure With Preserved Ejection Fraction Is Characterized by Dynamic Impairment of Active Relaxation and Contraction of the Left Ventricle on Exercise and Associated With Myocardial Energy DeficiencyJACC, 2009